← Open Payments lookup

MICHAEL FLANAGAN: Open Payments

NPI 1851453252 · BRYN MAWR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,219 in 57 payments from 20 companies in 2025. Trend: 2023 $1,154 · 2024 $1,149 · 2025 $1,219

Food & beverage: $1,219
CompanyPaymentsAmount
ABBVIE INC.8$148
Novo Nordisk Inc5$127
Lilly USA, LLC6$113
AstraZeneca Pharmaceuticals LP6$102
Lundbeck LLC4$77
Abbott Laboratories3$72
Bayer Healthcare Pharmaceuticals Inc.3$68
Daiichi Sankyo Inc.2$58
Axsome Therapeutics, Inc.2$56
Amgen Inc.3$54

Products named: REXULTI, FREESTYLE LIBRE 3, AIRSUPRA, Kerendia, INJECTAFER, UBRELVY, Auvelity, QULIPTA.

Industry payments across PA — which companies pay providers there.